(Total Views: 470)
Posted On: 08/24/2023 10:36:40 AM
Post# of 155038
CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury: Cell
Finally, in a large clinical cohort of stroke patients, carriers for a naturally occurring loss-of-function mutation in CCR5 (CCR5-Δ32) exhibited greater recovery of neurological impairments and cognitive function. In summary, CCR5 is a translational target for neural repair in stroke and TBI and the first reported gene associated with enhanced recovery in human stroke.
And the stock sits at 0.20 ???
Finally, in a large clinical cohort of stroke patients, carriers for a naturally occurring loss-of-function mutation in CCR5 (CCR5-Δ32) exhibited greater recovery of neurological impairments and cognitive function. In summary, CCR5 is a translational target for neural repair in stroke and TBI and the first reported gene associated with enhanced recovery in human stroke.
And the stock sits at 0.20 ???
(8)
(0)
